NCT01865500View on ClinicalTrials.gov

Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD Exacerbations

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Budesonide 4 mg

It will be evaluated at baseline, 24 h, 48 h and before discharge

DRUG

Budesonide 8 mg

Baseline FEV1 and before discharge FEV1 were evaluated

DRUG

Metil prednisolone

Trial Locations (1)

25240

Ataturk University Faculty of Medicine Pulmonary Disease Department, Erzurum

All Listed Sponsors
lead

Ataturk University

OTHER

NCT01865500 - Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD Exacerbations | Biotech Hunter | Biotech Hunter